Inactive Instrument
ASCENT INDUSTRIES CORP Stock OTC Markets
Stocks
PGTMF
CA04365B1067
Pharmaceuticals
OTC Markets Traded| Market Cap | 3.92M 2.75M 2.44M 2.28M 2.08M 264M 3.96M 27.61M 10.7M 135M 10.33M 10.11M 434M | P/E 2024 |
-1.85x | P/E 2025 | -3.69x |
|---|---|---|---|---|---|
| Enterprise Value | 5.43M 3.81M 3.38M 3.16M 2.88M 366M 5.48M 38.21M 14.81M 187M 14.29M 13.98M 600M | EV / Sales 2024 |
0.67x | EV / Sales 2025 | 0.89x |
| Free-Float |
82.94% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +3.92% |
| Manager | Title | Age | Since |
|---|---|---|---|
Philip Campbell
CEO | Chief Executive Officer | - | 2020-05-14 |
Jason Vandenberg
DFI | Director of Finance/CFO | 49 | 2022-01-17 |
Aron Tegenfeldt
PRN | Corporate Officer/Principal | - | 2022-07-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Philip Campbell
BRD | Director/Board Member | - | 2020-05-14 |
Drew Malcolm
BRD | Director/Board Member | - | 2020-06-23 |
Herb Dhaliwal
CHM | Chairman | 73 | 2026-04-22 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.92% | -.--% | - | - | 2.75M | |
| -0.61% | -3.43% | +36.07% | +115.04% | 1,019B | |
| -1.02% | -5.60% | +35.72% | +64.63% | 617B | |
| +1.11% | -0.58% | +12.36% | +77.95% | 464B | |
| +0.34% | -3.01% | +61.79% | +41.24% | 356B | |
| -0.95% | -4.05% | +20.54% | +41.71% | 333B | |
| -1.46% | -2.89% | +10.57% | +32.81% | 267B | |
| -1.35% | -5.43% | -6.17% | +8.98% | 244B | |
| -1.04% | -2.79% | +35.30% | +51.84% | 218B | |
| -1.87% | -4.10% | +28.44% | +93.66% | 179B | |
| Average | -0.29% | -3.54% | +26.07% | +58.65% | 410.8B | |
| Weighted average by Cap. | -0.60% | -3.54% | +29.07% | +70.57% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 9.92M 6.96M 6.19M 5.77M 5.26M 669M 10.02M 69.86M 27.07M 342M 26.14M 25.57M 1.1B | 12.12M 8.5M 7.56M 7.05M 6.43M 818M 12.24M 85.35M 33.07M 418M 31.93M 31.24M 1.34B |
| Net income | -2.77M -1.95M -1.73M -1.61M -1.47M -187M -2.8M -19.52M -7.56M -95.6M -7.3M -7.14M -307M | -1.84M -1.29M -1.15M -1.07M -976K -124M -1.86M -12.96M -5.02M -63.48M -4.85M -4.74M -204M |
| Net Debt | 1.37M 964K 857K 800K 729K 92.72M 1.39M 9.68M 3.75M 47.4M 3.62M 3.54M 152M | 1.51M 1.06M 938K 876K 798K 102M 1.52M 10.6M 4.11M 51.9M 3.97M 3.88M 167M |
Employees
-
Sector
Pharmaceuticals
